Centessa Pharmaceuticals PLC ADR
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $6,912 | $0 |
Gross Profit | -236 | -239 | 6,664 | -236 |
EBITDA | -43,793 | -35,829 | -35,235 | -38,695 |
EBIT | -44,029 | -36,069 | -35,484 | -38,931 |
Net Income | -43,865 | -38,024 | -37,157 | -38,648 |
Net Change In Cash | 0 | 0 | 6,912 | 0 |
Free Cash Flow | -37,264 | -37,264 | -31,128 | -37,435 |
Cash | 127,371 | 118,218 | 128,030 | 171,498 |
Basic Shares | 109,489 | 99,887 | 97,923 | 96,648 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2020-12-31 |
|---|---|---|---|
Revenue | $6,879 | $0 | $0 |
Gross Profit | 6,066 | -130 | |
EBITDA | -171,133 | -207,941 | -10,285 |
EBIT | -171,946 | -208,071 | -10,291 |
Net Income | -151,670 | -216,207 | -11,041 |
Net Change In Cash | 6,879 | 0 | 0 |
Free Cash Flow | -161,133 | -201,683 | -10,630 |
Cash | 128,030 | 393,644 | 7,227 |
Basic Shares | 96,177 | 93,400 | 142,057 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.40 |
2024-03-31 | -$0.38 |
2023-12-31 | -$0.38 |
2023-09-30 | -$0.40 |
